# Centene: how the business works

> For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Centene Corporation · NYSE: CNC · Sector: Health Care

Updated for Q3 FY2026 · checked Nov 20, 2026

This is the plain-text version of https://cityfort.co/stocks/centene. Source ids in [brackets] refer to the list at the end. Credit: "Cityfort, Centene: how the business works", with the page URL.

## The 30-second summary

Centene runs health plans, mostly paid for by governments, for 27.6 million members at Dec 31, 2025. It earns the gap between premiums and members' medical bills, which took 91.9% of premiums in FY2025. FY2025 total revenues were $194.8 billion, with a $6,674 million net loss that included $7,311 million of impairment charges.

## 5 points

- **What it sells:** Centene runs Medicaid, Medicare and Marketplace health plans for 27.6 million members at Dec 31, 2025, with total revenues of $194.8 billion in FY2025. [S4]
- **Who pays it:** In FY2025, Centene's Medicaid segment, paid by states, brought in 57% of external revenues, Commercial (mostly Marketplace plans) 21%, Medicare 19% and Other 3%. [S4]
- **What it keeps from $100:** Of every $100 that came in during FY2025, Centene spent $80.32 on medical bills and lost $3.40 after $7,311 million of impairment charges; adjusted net earnings, a non-GAAP measure, were $1,028 million. [S4]
- **Where the operating profit comes from:** FY2025 gross margin (premium and service revenues less medical and service costs) was $5,690 million in Medicaid, $5,101 million in Commercial, $2,983 million in Medicare and $435 million in Other. [S4]
- **The one thing to watch:** The health benefits ratio was 92.7% in Q3 FY2026; on Oct 27, 2026, Centene said it expects 90.4% to 91.1% for full-year 2026. [S15]

## What does Centene sell?

Centene runs health plans that governments mostly pay for. States hire it to run Medicaid, the health program for people with low incomes. It also sells Medicare plans for people 65 and over, and individual plans on the Affordable Care Act Marketplace.

- **Medicaid plans:** Health coverage that states pay Centene to manage, including care for children, pregnant women, disabled adults and long-term care. 12.5 million members in 30 states at Dec 31, 2025. [S4]
- **Medicare Advantage (Wellcare):** Private plans that replace traditional Medicare for people 65 and over, including plans for people who also qualify for Medicaid. 1.0 million members in 32 states at Dec 31, 2025. [S4]
- **Medicare drug plans:** Stand-alone prescription drug plans (PDP) for Medicare members, sold in all 50 states and DC. 8.1 million members at Dec 31, 2025. [S4]
- **Marketplace plans (Ambetter Health):** Individual health insurance bought on the Affordable Care Act exchanges, often with federal subsidies. 5.5 million members in 29 states at Dec 31, 2025. [S4]
- **Other services:** A specialty pharmacy (AcariaHealth), vision and dental services, primary care centers in Florida and the Magellan Health behavioral health business, which Centene agreed to sell in December 2025. [S4]

## Who pays Centene?

- **State Medicaid agencies (57.0% of revenue):** States pay a monthly premium per Medicaid member under multi-year contracts that are re-bid. [S4]
- **Marketplace members and federal subsidies (21.0% of revenue):** Individuals buy Ambetter Health plans; the federal government pays part of many premiums through tax credits. [S4]
- **Medicare program and its members (19.0% of revenue):** The federal Centers for Medicare and Medicaid Services (CMS) pays for Medicare Advantage and drug plans, with members paying part of some premiums. [S4]
- **Other customers (3.0% of revenue):** Payers for specialty pharmacy, behavioral health, vision and dental services. [S4]
- **Customer concentration:** No single customer was more than 10% of Centene's total revenues in 2023, 2024 or 2025. Most revenue comes from state Medicaid contracts, and Florida and New York were each about 10% or more of Medicaid premium revenues in 2025. [S4]

## Where the money went (FY2025)

1. States, the federal government and members paid $171,556 million of premiums in FY2025, and services added $3,025 million.
2. Centene also collected $20,196 million of state premium taxes, and its investments earned $1,572 million.
3. Members' medical bills took $157,702 million, or 91.9% of premiums.
4. Running costs took $15,574 million, and premium taxes paid to states were $20,538 million.
5. Impairment charges of $7,311 million left a $6,674 million net loss for the year.

Sources: S4.

## Key numbers by year (US$ million)

Financials: consolidated, US$ million. Fiscal years are the company's own: December 31. Centene's fiscal year matches the calendar year: FY2025 ended Dec 31, 2025, and Q3 FY2026 ended Sep 30, 2026. — = not shown on the page.

| Year | Revenue | EBITDA | EBITDA margin | Net profit | Net margin | EPS (US$ per share, diluted) | Operating cash flow | Capital spending | Free cash flow | Sources |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY2021 | 125,982 | — | — | 1,347 | 1.1% | 2.28 | 4,205 | 910 | — | S14 |
| FY2022 | 144,547 | — | — | 1,202 | 0.8% | 2.07 | 6,261 | 1,004 | — | S13 |
| FY2023 | 153,999 | — | — | 2,702 | 1.8% | 4.95 | 8,053 | 799 | — | S12 |
| FY2024 | 163,071 | — | — | 3,305 | 2.0% | 6.31 | 154 | 644 | — | S8 |
| FY2025 | 194,777 | — | — | −6,674 | −3.4% | −13.53 | 5,088 | 767 | — | S4 |

- EBITDA here = operating income plus depreciation and amortization (from the cash flow statement).
- Net profit is the share belonging to the company's owners.
- For an insurer, revenue is total revenue including premiums and investment income, as on the page.

## Who owns Centene? (as of Mar 13, 2026)

Centene's common stock carries one vote per share. Its 14 directors and executive officers together owned 1,823,921 shares, under 1%, as of Mar 13, 2026 (2026 proxy). Holder rows come from filings of different dates and are never added together. [S31, S1]

| Class | Shares (millions) | Votes per share | % of shares | % of votes | Traded | Sources |
| --- | --- | --- | --- | --- | --- | --- |
| Common stock (494,973 thousand shares outstanding at Sep 30, 2026 (Q3 FY2026 10-Q).) | 494.97 | 1 | 100.0% | 100.0% | Yes | S1 |

Holders of 5% or more (each row shows the date of its own filing):

| Holder | Shares | Votes | As of | Note | Sources |
| --- | --- | --- | --- | --- | --- |
| The Vanguard Group | 12.4% | — | Feb 13, 2024 | 61,190,588 shares, from a Schedule 13G/A filed Feb 13, 2024, as listed in the 2026 proxy. | S31 |
| BlackRock, Inc. | 7.8% | — | Jul 16, 2025 | 38,215,413 shares, from a Schedule 13G/A filed Jul 16, 2025, as listed in the 2026 proxy. | S31 |
| AQR Capital Management | 6.5% | — | Mar 13, 2026 | 31,798,738 shares, as listed in the 2026 proxy. | S31 |

## What could go wrong

### Medical costs above what was priced

Centene sets premiums before the year starts. Medical costs took 87.7% of premiums in FY2023, 91.9% in FY2025 and 92.7% in Q3 FY2026. [S4, S15]

What to watch: The health benefits ratio each quarter, against the 90.4% to 91.1% range Centene gave for 2026 on Oct 27, 2026.

### Changes to government health programs

Extra federal Marketplace subsidies ended after 2025. A July 2025 federal law adds Medicaid work requirements and more frequent eligibility checks, largely from 2027. Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026. [S1, S15]

What to watch: Marketplace and Medicaid membership each quarter.

### Losing or re-bidding state contracts

Most revenue comes from state Medicaid contracts that are re-bid, and Florida and New York were each about 10% or more of Medicaid premium revenues in 2025. From Jan 1, 2027, about 175,000 Health Net members in California move to fee-for-service Medi-Cal. [S4, S1]

What to watch: State contract awards, renewals and losses in 8-Ks and earnings releases.

### Risk-adjustment estimates

Marketplace insurers pay into or receive from a federal risk-adjustment pool, settled after the year ends. In June 2026, CMS's final 2025 figures cut Centene's net payable by $541 million. [S1]

What to watch: Changes to risk-adjustment estimates in each 10-Q.

### Shareholder lawsuits

The Q3 FY2026 10-Q says a proposed class action filed on Jul 9, 2025 alleges false and misleading statements about Centene's 2025 earnings guidance, and five derivative suits followed. Centene denies wrongdoing; the 10-Q says an adverse outcome could have a material impact. [S1]

What to watch: Court rulings or settlements disclosed in 10-Qs.

### Debt and cash held in regulated units

Total debt was $15,542 million at Sep 30, 2026. Most cash sits in state-regulated subsidiaries; $175 million was available for general corporate use. [S1, S15]

What to watch: Debt to capitalization (41.1% at Sep 30, 2026) and dividends from subsidiaries to the parent.

## What to watch

Next: Q4 and full-year FY2026 results, Date not announced yet.

- **The health benefits ratio:** It was 92.7% in Q3 FY2026. On Oct 27, 2026, Centene said it expects 90.4% to 91.1% for full-year 2026.
- **FY2026 results against guidance:** On Oct 27, 2026, Centene said it expects 2026 GAAP diluted EPS above $3.46 and adjusted diluted EPS, a non-GAAP measure, above $5.20.
- **Marketplace and Medicaid members:** Marketplace had 3.40 million members and Medicaid 11.90 million at Sep 30, 2026, both lower than at Dec 31, 2025.
- **Contracts and lawsuits:** About 175,000 California Health Net members move to fee-for-service Medi-Cal from Jan 1, 2027. The shareholder suits are updated in each 10-Q.

## Sources

- S1: Form 10-Q for Q3 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000192/0001071739-26-000192-index.htm (published Oct 27, 2026)
- S2: Form 10-Q for Q2 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000153/0001071739-26-000153-index.htm (published Jul 28, 2026)
- S3: Form 10-Q for Q1 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000098/0001071739-26-000098-index.htm (published Apr 28, 2026)
- S4: Form 10-K for FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000049/0001071739-26-000049-index.htm (published Feb 17, 2026)
- S5: Form 10-Q for Q3 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000183/0001071739-25-000183-index.htm (published Oct 29, 2025)
- S6: Form 10-Q for Q2 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000150/0001071739-25-000150-index.htm (published Jul 25, 2025)
- S7: Form 10-Q for Q1 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000086/0001071739-25-000086-index.htm (published Apr 25, 2025)
- S8: Form 10-K for FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000027/0001071739-25-000027-index.htm (published Feb 18, 2025)
- S9: Form 10-Q for Q3 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173924000200/0001071739-24-000200-index.htm (published Oct 25, 2024)
- S10: Form 10-Q for Q2 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173924000157/0001071739-24-000157-index.htm (published Jul 26, 2024)
- S11: Form 10-Q for Q1 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173924000097/0001071739-24-000097-index.htm (published Apr 26, 2024)
- S12: Form 10-K for FY2023. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173924000037/0001071739-24-000037-index.htm (published Feb 20, 2024)
- S13: Form 10-K for FY2022. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173923000047/0001071739-23-000047-index.htm (published Feb 21, 2023)
- S14: Form 10-K for FY2021. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173922000071/0001071739-22-000071-index.htm (published Feb 22, 2022)
- S15: Earnings release for Q3 FY2026 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000194/a20261027ex991pressrelease.htm (published Oct 27, 2026)
- S16: Earnings release for Q2 FY2026 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000154/a20260728ex991pressrelease.htm (published Jul 28, 2026)
- S17: Earnings release supplement for Q2 FY2026 (8-K Ex. 99.2). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000154/a20260728ex992pressrelease.htm (published Jul 28, 2026)
- S18: Earnings release for Q1 FY2026 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000099/a20260428ex991pressrelease.htm (published Apr 28, 2026)
- S19: Earnings release for Q4 FY2025 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000031/a20260206ex991pressrelease.htm (published Feb 6, 2026)
- S20: Earnings release for Q3 FY2025 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000185/a20251029ex991pressrelease.htm (published Oct 29, 2025)
- S21: Earnings release for Q2 FY2025 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000151/a20250725ex991pressrelease.htm (published Jul 25, 2025)
- S22: Earnings release for Q1 FY2025 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000087/a20250425ex991pressrelease.htm (published Apr 25, 2025)
- S23: Earnings release for Q4 FY2024 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000013/a20250204ex991pressrelease.htm (published Feb 4, 2025)
- S24: Earnings release for Q3 FY2024 (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173924000201/a20241025ex991pressrelease.htm (published Oct 25, 2024)
- S25: Form 8-K filed Jul 1, 2025 (2025 guidance withdrawn). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000128/cnc-20250701.htm (published Jul 1, 2025)
- S26: Form 8-K filed Mar 5, 2025 (credit agreement). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173925000040/cnc-20250305.htm (published Mar 5, 2025)
- S27: Form 8-K filed Oct 8, 2026 (redemption of 2027 notes). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000186/cnc-20261008.htm (published Oct 8, 2026)
- S28: Form 8-K filed Sep 16, 2026 (conference, guidance reaffirmed). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000172/cnc-20260916.htm (published Sep 16, 2026)
- S29: Form 8-K filed Jul 29, 2026 (partial redemption of 2027 notes). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000162/cnc-20260729.htm (published Jul 29, 2026)
- S30: Form 8-K filed Mar 10, 2026 (conference, guidance reaffirmed). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000056/cnc-20260310.htm (published Mar 10, 2026)
- S31: Proxy statement (DEF 14A), 2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1071739/000107173926000077/cnc-20260326.htm (published Mar 26, 2026)
